AstraZeneca Pharma India receives CDSCO approval for tumour-agnostic use of Trastuzumab Deruxtecan EP News Bureau Oct 6, 2025 New indication approved for treatment of unresectable or metastatic HER2-positive solid tumours in adult patients after prior…
